BeOne Medicines Ltd. (ONC) › Operating Cash FlowBeOne Medicines Ltd. (ONC) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2015: -$39.84M2016: -$89.51M2017: $12.75M2018: -$547.72M2019: -$750.27M2020: -$1.28B2021: -$1.30B2022: -$1.50B2023: -$1.16B2024: -$140.63M2025: $1.13B$1.13B2015Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$1.13B+901.8%2024-$140.63M+87.8%2023-$1.16B+22.7%2022-$1.50B-15.2%2021-$1.30B-1.2%2020-$1.28B-71.1%2019-$750.27M-37.0%2018-$547.72M-4395.1%2017$12.75M+114.2%2016-$89.51M-124.7%2015-$39.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share